- Home
- BLMN vs ATTO Comparison
BLMN vs ATTO Comparison
Compare BLMN & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BLMN | ATTO |
|---|---|---|
| Founded | 1988 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 851.9M | 1.0B |
| IPO Year | 2012 | 2026 |
Fundamental Metrics
Financial Performance| Metric | BLMN | ATTO |
|---|---|---|
| Price | $10.06 | $14.09 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 5 |
| Target Price | $11.86 | ★ $42.20 |
| AVG Volume (30 Days) | ★ 2.4M | 424.0K |
| Earning Date | 11-06-2026 | 09-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 106.71 | N/A |
| EPS | ★ 1.01 | N/A |
| Revenue | ★ $4,213,346,000.00 | N/A |
| Revenue This Year | $0.65 | N/A |
| Revenue Next Year | $1.66 | N/A |
| P/E Ratio | $10.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.19 | $12.94 |
| 52 Week High | $12.63 | $28.00 |
Technical Indicators
Market Signals| Indicator | BLMN | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 64.36 | 34.89 |
| Support Level | $7.74 | $12.94 |
| Resistance Level | $11.75 | $15.54 |
| Average True Range (ATR) | 0.44 | 1.20 |
| MACD | 0.24 | -0.10 |
| Stochastic Oscillator | 85.62 | 29.25 |
Price Performance
Historical ComparisonAbout BLMN Bloomin' Brands Inc.
Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.
About ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.